Statistics
Publications
3
Citations
207
H-Index
3
Active since
2020
Natalie Bublitz is an author at Heidelberg University specializing in oncogenic signaling pathways, cancer cell signaling, and molecular oncology.
Publications per year
2020–2024
3
3
Combination Therapies with CDK4/6 Inhibitors to Treat <i>KRAS-</i> Mutant Pancreatic Cancer
Craig M. Goodwin, Andrew M. Waters, Jennifer E. Klomp et al. · Cancer Research · 2022 · 160 citations · Full text
Medicine, Oncology, Pharmacology +17
SFPQ Depletion Is Synthetically Lethal with BRAFV600E in Colorectal Cancer Cells
Kathleen Klotz‐Noack, Bertram Klinger, Maria Rivera et al. · Cell Reports · 2020 · 35 citations · Full text
Combination Therapies with CDK4/6 Inhibitors to Treat KRAS-Mutant Pancreatic Cancer.
Mareen Lüthen, Jennifer E. Klomp, Bjoern Papke et al. · UNC Libraries · 2024 · 12 citations · Full text
Medicine, Oncology, Pharmacology +15
1–3 of 3